- Home
- MREO vs FBYD Comparison
MREO vs FBYD Comparison
Compare MREO & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- FBYD
- Stock Information
- Founded
- MREO 2015
- FBYD 2021
- Country
- MREO United Kingdom
- FBYD United States
- Employees
- MREO N/A
- FBYD N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- FBYD
- Sector
- MREO Health Care
- FBYD
- Exchange
- MREO Nasdaq
- FBYD Nasdaq
- Market Cap
- MREO 424.5M
- FBYD 300.5M
- IPO Year
- MREO N/A
- FBYD N/A
- Fundamental
- Price
- MREO $2.41
- FBYD $7.78
- Analyst Decision
- MREO Strong Buy
- FBYD
- Analyst Count
- MREO 7
- FBYD 0
- Target Price
- MREO $7.71
- FBYD N/A
- AVG Volume (30 Days)
- MREO 1.5M
- FBYD 17.6K
- Earning Date
- MREO 05-19-2025
- FBYD 05-19-2025
- Dividend Yield
- MREO N/A
- FBYD N/A
- EPS Growth
- MREO N/A
- FBYD N/A
- EPS
- MREO N/A
- FBYD 1.41
- Revenue
- MREO N/A
- FBYD $6,745,000.00
- Revenue This Year
- MREO N/A
- FBYD N/A
- Revenue Next Year
- MREO $56.11
- FBYD N/A
- P/E Ratio
- MREO N/A
- FBYD $5.51
- Revenue Growth
- MREO N/A
- FBYD N/A
- 52 Week Low
- MREO $1.58
- FBYD $3.62
- 52 Week High
- MREO $5.02
- FBYD $13.25
- Technical
- Relative Strength Index (RSI)
- MREO 50.36
- FBYD 53.88
- Support Level
- MREO $2.28
- FBYD $6.48
- Resistance Level
- MREO $2.75
- FBYD $8.00
- Average True Range (ATR)
- MREO 0.16
- FBYD 0.81
- MACD
- MREO -0.00
- FBYD 0.08
- Stochastic Oscillator
- MREO 27.66
- FBYD 88.67
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.